Daily Stock Analysis, CGNT, Cogentix Medical Inc, priceseries

Cogentix Medical Inc. Daily Stock Analysis
Stock Information
Open
2.93
Close
2.98
High
2.99
Low
2.86
Previous Close
2.94
Daily Price Gain
0.04
YTD High
3.26
YTD High Date
Sep 14, 2017
YTD Low
1.55
YTD Low Date
May 17, 2017
YTD Price Change
0.89
YTD Gain
42.58%
52 Week High
3.26
52 Week High Date
Sep 14, 2017
52 Week Low
1.52
52 Week Low Date
Nov 7, 2016
52 Week Price Change
1.29
52 Week Gain
76.33%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Feb 20. 2015
2.55
Feb 23. 2015
2.72
1 Trading Days
6.86%
Link
LONG
Feb 27. 2015
2.50
Mar 2. 2015
2.62
1 Trading Days
5.02%
Link
LONG
Nov 2. 2015
1.35
Nov 16. 2015
1.48
10 Trading Days
9.40%
Link
LONG
Dec 24. 2015
1.41
Dec 28. 2015
1.50
1 Trading Days
6.74%
Link
LONG
Jul 5. 2016
1.04
Jul 14. 2016
1.09
7 Trading Days
5.06%
Link
LONG
Nov 10. 2016
1.66
Nov 28. 2016
2.12
11 Trading Days
27.50%
Link
LONG
Jul 25. 2017
1.76
Aug 10. 2017
2.24
12 Trading Days
27.10%
Link
LONG
Oct 4. 2017
2.72
Oct 18. 2017
2.87
10 Trading Days
5.41%
Link
Company Information
Stock Symbol
CGNT
Exchange
NasdaqCM
Company URL
http://http://www.cogentixmedical.com
Company Phone
952-426-6140
CEO
Darin Hammers
Headquarters
Minnesota
Business Address
5420 FELTL ROAD, MINNETONKA, MN 55343
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Appliances & Equipment
CIK
0000894237
About

Cogentix Medical, Inc., a medical device company, designs, develops, manufactures, and markets products for the urology market and flexible endoscopy. The company principally offers Urgent PC neuromodulation system for the overactive bladder and a...

Description

Cogentix Medical, Inc., a medical device company, designs, develops, manufactures, and markets products for the urology market and flexible endoscopy. The company principally offers Urgent PC neuromodulation system for the overactive bladder and associated symptoms of urge incontinence, urinary urgency and urinary frequency; and Macroplastique implants, an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency. It also provides EndoSheath system, which combines endoscopic technology with a sterile and disposable microbial barrier for flexible endoscopy. In addition, the company offers Macroplastique products for treatment of vesicoureteral reflux; PTQ Implants, which provide a minimally-invasive, soft-textured permanent implant for treatment of fecal incontinence; Urgent PC System for the treatment of fecal incontinence; and VOX Implants, a silicone elastomer bulking material for vocal cord rehabilitation applications, as well as distributes wound care products. The company sells its products primarily to urologists, urogynecologists, and gynecologists through a direct sales organization in the United Kingdom, the Netherlands, Switzerland, Belgium, Finland, Sweden, and Denmark, as well as through distributors in other markets. Cogentix Medical, Inc. was founded in 1987 and is headquartered in Minnetonka, Minnesota.